The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:HPB (Oxford)
Prif Awduron: Sarpel, Umut, Spivack, John H., Berger, Yaniv, Heskel, Marina, Aycart, Samantha N., Sweeney, Robert, Edwards, Martin P., Labow, Daniel M., Kim, Edward
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/
https://ncbi.nlm.nih.gov/pubmed/27154804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg